Oppenheimer Asset Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $385K | Buy |
1,714
+24
| +1% | +$5.98K | ﹤0.01% | 926 |
|
|
2025
Q4 | $407K | Sell |
1,690
-137
| -7% | -$35K | 0.01% | 860 |
|
|
2025
Q3 | $500K | Sell |
1,827
-175
| -9% | -$47.8K | 0.01% | 903 |
|
|
2025
Q2 | $517K | Sell |
2,002
-6,937
| -78% | -$1.65M | 0.01% | 874 |
|
|
2025
Q1 | $2M | Sell |
8,939
-741
| -8% | -$173K | 0.02% | 519 |
|
|
2024
Q4 | $2.21M | Sell |
9,680
-309
| -3% | -$74.4K | 0.03% | 499 |
|
|
2024
Q3 | $2.44M | Sell |
9,989
-188
| -2% | -$42K | 0.03% | 488 |
|
|
2024
Q2 | $1.95M | Buy |
10,177
+674
| +7% | +$137K | 0.02% | 528 |
|
|
2024
Q1 | $1.88M | Sell |
9,503
-572
| -6% | -$105K | 0.03% | 507 |
|
|
2023
Q4 | $1.73M | Buy |
10,075
+537
| +6% | +$82.5K | 0.02% | 557 |
|
|
2023
Q3 | $1.41M | Sell |
9,538
-88
| -0.9% | -$15.9K | 0.02% | 597 |
|
|
2023
Q2 | $2.1M | Sell |
9,626
-107
| -1% | -$23.8K | 0.03% | 497 |
|
|
2023
Q1 | $2.13M | Sell |
9,733
-664
| -6% | -$144K | 0.03% | 472 |
|
|
2022
Q4 | $2.16M | Sell |
10,397
-67
| -0.6% | -$14.7K | 0.03% | 451 |
|
|
2022
Q3 | $2.28M | Sell |
10,464
-627
| -6% | -$143K | 0.04% | 417 |
|
|
2022
Q2 | $2.33M | Sell |
11,091
-17
| -0.2% | -$3.62K | 0.04% | 426 |
|
|
2022
Q1 | $2.69M | Sell |
11,108
-252
| -2% | -$61K | 0.04% | 442 |
|
|
2021
Q4 | $2.96M | Buy |
11,360
+92
| +0.8% | +$23.9K | 0.04% | 435 |
|
|
2021
Q3 | $2.97M | Sell |
11,268
-378
| -3% | -$103K | 0.04% | 408 |
|
|
2021
Q2 | $2.87M | Buy |
11,646
+129
| +1% | +$27.1K | 0.04% | 426 |
|
|
2021
Q1 | $2.23M | Buy |
11,517
+464
| +4% | +$93K | 0.03% | 479 |
|
|
2020
Q4 | $2.35M | Sell |
11,053
-281
| -2% | -$56K | 0.04% | 436 |
|
|
2020
Q3 | $1.94M | Sell |
11,334
-169
| -1% | -$31.2K | 0.04% | 435 |
|
|
2020
Q2 | $2.21M | Sell |
11,503
-1,946
| -14% | -$318K | 0.05% | 379 |
|
|
2020
Q1 | $1.98M | Sell |
13,449
-412
| -3% | -$65.6K | 0.05% | 353 |
|
|
2019
Q4 | $2.15M | Sell |
13,861
-169
| -1% | -$24.4K | 0.05% | 398 |
|
|
2019
Q3 | $1.9M | Sell |
14,030
-466
| -3% | -$61.1K | 0.04% | 421 |
|
|
2019
Q2 | $1.77M | Buy |
14,496
+187
| +1% | +$20.7K | 0.04% | 441 |
|
|
2019
Q1 | $1.49M | Buy |
14,309
+60
| +0.4% | +$6.19K | 0.03% | 478 |
|
|
2018
Q4 | $1.62M | Sell |
14,249
-527
| -4% | -$56.5K | 0.04% | 413 |
|
|
2018
Q3 | $1.71M | Sell |
14,776
-345
| -2% | -$37.8K | 0.04% | 458 |
|
|
2018
Q2 | $1.57M | Sell |
15,121
-1,123
| -7% | -$114K | 0.04% | 459 |
|
|
2018
Q1 | $1.6M | Sell |
16,244
-1,647
| -9% | -$156K | 0.04% | 444 |
|
|
2017
Q4 | $1.38M | Hold |
17,891
| – | – | 0.04% | 498 |
|
|
2017
Q3 | $1.38M | Buy |
17,891
+85
| +0.5% | +$6.5K | 0.04% | 500 |
|
|
2017
Q2 | $1.39M | Sell |
17,806
-312
| -2% | -$22.3K | 0.04% | 475 |
|
|
2017
Q1 | $1.3M | Buy |
+18,118
| New | +$1.25M | 0.04% | 489 |
|
Other funds holding RMD
VCM
VPM
DAM
Oppenheimer Asset Management's RMD Position: Q1 2026 in Review
Oppenheimer Asset Management increased its ResMed (RMD) stake by 1.4% in Q1 2026, buying an estimated $5.98K and bringing the position to 1,714 shares worth $385K. The position accounts for ﹤0.01% of the portfolio, ranked #926.
Oppenheimer Asset Management first reported a position in RMD in Q1 2017 and has held it in 37 quarters since. The position peaked at $2.97M in Q3 2021. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- Oppenheimer Asset Management held 1,714 shares of ResMed worth $385K as of Q1 2026.
- Oppenheimer Asset Management bought 24 ResMed shares in Q1 2026, an estimated $5.98K.
- ResMed made up ﹤0.01% of Oppenheimer Asset Management's portfolio in Q1 2026, its #926 holding.
- Oppenheimer Asset Management first reported a position in ResMed in Q1 2017 and has held it in 37 quarters since.
- Oppenheimer Asset Management's ResMed position peaked at $2.97M in Q3 2021.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on Oppenheimer Asset Management's 13F filing for Q1 2026, filed 24 Apr 2026.